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Summary.-The level of Gross cell-surface antigen (GCSAa) expression at the
surface of murine retrovirus-infected fibroblasts was determined by quantitative
absorption of the anti-GCSAa activity of a serum produced in syngeneic W/Fu rats
immunized against (C58NT)D lymphoma, and tested in a cytotoxicity assay against
ESG2 lymphoma cells.
While GCSAa was specifically expressed on Gross-type virus (G-MuLV)-induced
lymphoma cells, and while G-MuLV and G-related MuLV induced a high level of
GCSAa expression on murine fibroblasts, the Friend-Moloney-Rauscher (FMR)
group viruses (FMR MuLV) and xenotropic isolates were also able to induce a high
or intermediate level of GCSAa. Since GCSAa has been shown to be borne by glyco-
sylated precursors of the viral nucleocapside (gp95gag and gp85gag), the amount of
GCSAa expressed on these cells was compared to the level of cytoplasmic p30. In
G- and G-related MuLV-infected cell lines, a significant relationship was found
between the amount of GCSAa and the level of p30, whereas in FMR-MuLV or
xenotropic virus-infected cells the amount of GCSAa varied independently of the
p30 level. These results could explain the discrepancy in the specificity of expression
of GCSAa in vivo and in vitro.
RETROVIRUS-INDUCED) TUMOURS bear
specific virus-induced surface antigens
which could act as targets in the immuno-
logical control of the tumour (Bauer,
1974). Thus, lymphomas induced by the
Gross murine leukaemia virus (G-MuLV)
express the Gross cell surface antigen
(GCSA) which is specific for this MuLV
and is not expressed on lymphomas
induced by MuLV ofthe Friend-Moloney-
Rauscher (FMR) group (Old et al., 1965;
Geering et al., 1966). The specificity of
GCSA expression can however be ques-
tioned in studies of in vitro cultured cells,
since in vitro infection of fibroblasts by
FMR-MuLV can result in GCSA expression
(O'Donnel & Stockert, 1976). Therefore it
could be asked whether in vitro infections
by G-MuLV or FMR-MuLV result in a
quantitative rather than qualitative differ-
ence in GCSA expression. Since GCSA has
been demonstrated to be glycosylated
precursors of gag virus proteins (Led-
better & Nowinski, 1977; Snyder et al.,
1977) the comparison of the expression of
this cell-surface antigen with the intra-
cellular viral nucleocapside proteins could
provide a further insight into the gag gene
expression during infection by G-and
FMR-MuLV.
A specific determination of the level of
GCSA expression was therefore developed,
using quantitative absorption of the anti-
GCSAa activity of a W/Fu rat antiserum
defined by a cytotoxicity assay on E,G2
lymphoma target cells (Geering et al.,
1966, Herberman et al., 1972). GCSAa
induction by ecotropic G-MuLV or FMR-
MuLV and xenotropic murine retroviruses
was measured in relation to the level of
cytoplasmic viral nucleocapside p30 in the
same cells.D. GERLIER, S. GISSELBRECHT, B. GUILLEMAIN AND J. F. DORE
MATERIAL AND METHODS
Animals and tumours.-The Gross virus-
induced lymphoma (C58NT)D (Geering et al.,
1966) was maintained in ascitic form by
weekly transplantation in weanling syngeneic
W/Fu/Ico rats. The G-MuLV-induced lym-
phoma ESG2 (Old et al., 1965), R-MuLV-
induced lymphoma RBL5 (McCoy et al.,
1967), Graffi-virus (Gi-MuLV)-induced lym-
phoma GiL4 (Levy et al., 1968) and benzo(a)-
pyrene-induced lymphoma EL4 (Gorer, 1950)
were maintained in syngeneic C57BL/6/Ico
mice. Ico animals were purchased from
IFFA-CREDO (France). 129/Sv/Cp mice
were kindly provided by J. L. Guenet
(Institut Pasteur, Paris).
Antiserum.-Antiserum to the (C58NT)D
tumour was produced in a syngeneic W/Fu
rat by s.c. inoculation of 4 x 108 viable
tumour cells followed 4 weeks later by 5
booster injections of 2.108 viable tumour
cells (Gerlier et al., 1977a).
Cell lines and viruses.-Various tissue-
cultured cells of murine and non-murine
origin were maintained in RPMI 1629
medium supplemented with 10% foetal calf
serum, 100 u/ml of penicillin and 50 /g/ml of
streptomycin. Details ofthe lines and viruses
studied are given in Table I.
Quantitative absorption experiment and cyto-
toxicity. test.-For absorption experiments,
cells were prepared asfollows: lymphoma cells
propagated in vivo in ascitic form were
harvested and washed x 3 in phosphate
buffer (pH 7.4) 0-15M NaCl; ESG2 lym-
phoma cells and normal spleen cells were
prepared by mincing the spleen after perfu-
sion to remove red blood cells and were
washed similarly.
Monolayers of cultured cells were treated
with phosphate buffer containing 0-2 g/1
EDTA for a few minutes at 370C, and
washed in buffer without EDTA. All cell
suspensions were filtered on gauze to remove
aggregates and counted in a haemacytometer.
0-5 x 106 to 108 or 5 x 108 cells were pelleted
by centrifugation and resuspended in 130 IlI
of the anti (C58NT)D rat serum diluted
1:150 (2 dilutions above its 50% cytotoxic
activity on E,G2 lymphoma cells). The
mixture was incubated 45 min at room
temperature. After removal of cells by
centrifugation at 2000 g, the supernatant
was centrifuged for 1 h at 48,000 g to remove
any cell fragment which could exert an
anticomplementary effect. The residual cyto-
toxic activity against E,G2 cells was
determined by a complement-dependent cyto-
toxicity test as previously described (Gerlier
et al., 1977b).
Results are expressed as the percentage of
absorption (A) =C-T x 100,
where C is the cytotoxicityindex of unab-
sorbed serum diluted 1: 150 and T the cyto-
toxicity index of absorbed serum. When A
was plotted againstthe number of absorbing
cells in a log/log scale, the relationship was
found to be linear, as demonstrated byDexter
(1976), and could be expressed by the follow-
ing equation:
log(A)=a log(N) + b
where N is the number of absorbing cells, a
the slope ofthe straight line and b a constant
characteristic for each type of absorbing cell.
Typical curve is shown in Fig. 1.
Each cell type was characterized by the
number of cells (NA50) absorbing 50% of the
cytotoxic activity of 1 ,u of anti-(C58NT)D
serum diluted 1:150. Thus, NA50 reflects the
amount of GCSAa expressed on the surface
ofthis cell; and the lower the number of cells
necessary to absorb 50% of the serum
activity, the greater is the amount of GCSAa
expressed by the cell type involved.
MuLVp30 radioimmunoassay.-The major
murine leukaemia virus internal protein,
MuLV p30, was quantified by a competitive
radioimmunoprecipitation assay, as previ-
ously described (Gisselbrecht et al., 1978). A
purified Rauscher p30 donated by Dr W. P.
Parks (National Cancer Institute, Bethesda,
Maryland) was iodinated by the chloramine
T method (Greenwood et al., 1963). Goat
anti-xenotropic virus p30 serum was obtained
from Dr Gruber (NCI, Bethesda). Rabbit
antigoat y-globulin sera were prepared in our
laboratory. The concentrations of cytoplas-
mic p30 in cultured cell lines were measured
as follows: cells were harvested mechanically
from culture flasks when monolayers had
reached a subconfluent growth; after washing
them in 0O01M Tris buffer (pH 7.5) 01M
NaCl, cells were disrupted by brief ultra-
sonic treatment on ice. The resulting homo-
genates were centrifuged for 20 min at
3000 g and the supernatants stored at
-70°C until used. Protein concentrations
were assayed by the Lowry method. Homo-
genate supernatants used as competing
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FIG. 1.-Absorbing curve for EcG2 lym-
phoma cells: % of absorption of cytotoxic
activity ofanti-GCSAa serum as a function
of number of cells used to absorb (log/log
scale).
antigens were diluted in O-O1M phosphate
buffer (pH 7.4) containing 1% foetal calf
serum, 0.1% triton X100 and 300 ,ug/ml of
phenylmethane sulphonyl fluoride (Merk
Biochemicals). Results were expressed as
ng of p30/mg protein, as calculated by
comparison with the displacement observed
when purified p30 was used as the competing
antigen.
RESULTS
GCSAa definition and homogeneity of the
GCSAa quantitative assay
Since anti-(C58NT)D sera produced in
syngeneic W/Fu rats have been shown to
contain antibodies directed against several
antigenic specificities, as detailed in Table
II (Herberman, 1972), the GCSAa speci-
ficity of the serum used in these experi-
ments was controlled in a cytotoxicity
assay on E&G2 target cells. Data shown
in Table III indicate that a low number
of ESG2 or (C58NT)D cells absorbed the
cytotoxic activity of our anti-(C58NT)D
serum on E&G2 cells (NA5o= 0 79 x 105
and 0 77 x 105 respectively) whereas thy-
mocytes of 129/Sv mice, RBL5, EL4,
GiL4 and normal spleen cells were unable
to absorb this antibody specificity. A
nonspecific absorption effect can however
be detected when a large volume of
leukaemic cells was used (NA50 > 18 x 105).
The GCSAa quantitative assay also
yielded the degree of heterogeneity of the
antibodies, which is characteristic for the
antigen/antibody complex involved. This
heterogeneity is expressed as the slope of
the straight lines obtained when logs of
the percentage of absorption are plotted
against logs of the number of absorbing
cells (Dexter, 1976). The slopes of the
absorption curves for E&G2 and
TABLE II.-Dqfinition of antigens recognized by the syngeneic rat anti-C58NT serum*
Serum W/Fu rat serum anti-W/Fu (C58NT)D lymphoma
Test Complement-dependent cytotoxicity
Target cells ESG2 lymphoma RBL5 lymphoma thymocytes
(C57BL/6 mouse) (C57BL/6 mouse) (129 mouse)
Antigen
phenotype
Antibody
phenotype
evidenced
GCSAa+
GCSAb +
GIx +
I
GCSAa
GCSAa-
GCSAb+
GIx -
I
GCSAb
GCSAa-
GCSAb -
Gix +
I
Glx
* Compiled from Geering et al. (1966); Herberman (1972).
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TABLE III.-Quantitative specific GCSAa
expression on leukaemic cells
C57BL/6 normal
spleen cells
E,3G2
(C58NT)D
RBL5
129 Thymocytes
GiL4
EL4
NA5o*
>38x 105
0 79x 105
0-77x 105
( > 18 x 105)t
> 38 x 105
(>20x 105)t
(>20x 105)t
* Number ofcells absorbing 50% ofcytotoxic acti-
-vity of 1 ,ul dliluted 1: 150 sertum.
t Nonspecific absorption.
(C58NT)D cells were similar (I 84 and
1 88 respectively). Slopes ofthe absorption
curve were also calculated for each set of
cultured cells and compared to those of
lymphoma cells. Cultured cells were
divided into 3 groups: cells infected with
G and G-related MuLV, cells infected with
MuLV of the FMR group and cells
infected with xenotropic viruses. As indi-
cated in Table IV, the statistical analysis
(homogeneity test) of the means and
standard deviations of the different slopes
showed that the absorption curves of the
3 groups of cells have slopes which do not
differ significantly from each other. Fur-
thermore, the general mean of the slopes
for the 3 groups (1P82+0 42) was very
close to that of the absorption curve
of GCSAa reference cells ETG2 and
(C58NT)D.
We may therefore consider that the
quantitative absorption test used in these
experiments allowed a measurement of
GCSAa at the surface of cultured cells. It
should be stressed that this method, used
to express the amount of GCSAa as the
number of cells needed to absorb 50% of
the anti-GCSAa activity (NA50) is highly
reproducible, results were actually repro-
duced several times with a given cell and
the same findings were also obtained with
another anti-(C58NT)D serum (data not
shown).
In vitro GCSAa expression induced by
G-MuLV and G-related viruses
Since a large number of absorbing
cells/,ul of serum could lead to unspecific
absorption, we have chosen an NA50 of
5 x 105 cultured cells/1l as the upper limit
of specific absorption. As indicated in
Fig. 2, the infection of fibroblasts with
Gross virus induced a high level of GCSAa
expression, depending upon the host cells
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FIG. 2.- Quantitative GCSAa expression on
G-related MuLV-infected murine cells:
Number of cells (x 10-5) absorbing 50% of
the cytotoxic activity of 1 pl serum
diluted 1: 150.
TABLE IV. Slopes of absorption curve* of infected cultuared cells
Infecting viruses Mean S.d.
G and ecotropic 1 92 0 50
G-related MuLV o> 035
FMR-MuLV 1-80 J o>0 10 0 44 co>0 1()
01> 0-301
Xenotropie MuLV 1-74 J 0 33
All viruses together 1-82 0-42
* Mean and variance analysis according to Fislier (1924).
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FIG. 3.-Quantitative GCSAa expression on
FMR-MuLV-infected murine cells: Number
of cells (x 10-5) absorbing 50% of the
cytotoxic activity of 1 ul serum diluted
1:150.
(NA5o) ranging from 037 x 105 cells for
SC1-G to 1L55x 105 cells for 3T3FL(1)G.
Similarly, G-related endogenous viruses
induced a high GCSAa expression (NA50
ranging from 0065 x 105 cells for SC1-N
to 055 x 105 cells for 13-3-C).
In vitro GCSAa expression induced by
MuLV of the FMR group
Mouse cells infected with M-MuLV
expressed an intermediate level of GCSAa
activity, the NA50 of these cells ranging
from 1.15 x 105 cells for SL12P to 3-80 x
105 cells for 3T3-MLV2 (Fig. 3). By
contrast, infection with F-MuLV or R-
MuLV did not induce GCSAa activity
(NA5o0 5 x 105 cells for 3T3FL(1)-F,
NA50 = 4-9 x 105 cells for BxN-R) with
the exception of C3H cells (NAso= 1.58 x
105 cell for C3H-R). Thus, the GCSAa
expression induced by viruses from the
FMR-MuLV group was scattered over a
wider range than that induced by viruses
from the G-MuLV group.
In vitro GCSAa expression induced by
mouse xenotropic virus
Xenogenous cell lines producing xeno-
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FIG. 4.-Quantitative GCSAa expression on
xenotropic-virus-infected xenogenic fibro-
blasts: Number of cells (x 10-5) absorbing
50% of the cytotoxic activity of 1 ,ul
serum diluted 1:150.
tropic virus from Mus molossinus and
C57 leaden mouse expressed GCSAa at a
level equal to that of G-MuLV-infected
mouse cell lines (Fig. 4, NA50= 1-20 x 105
cells for 8155-MOL and 0 95 x 105 cells
for DOG-C57L). Xenotropic virus of
NZB induced only an intermediate level
ofGCSA (NA5o= 1-8 x 105 cells forCL1S2).
NIH-Swiss mouse xenotropic virus AT124
is also able to induce GCSAa activity,
strongly depending upon the infected cell;
from high induction in HUF cells (NA5o=
105 cells) to low induction in DOG cells
(NA5o= 4-36 x 105 cells (Fig. 4) and in
AT124 cells (NAso= 3-63 x 105 cells).
Relation between GCSAaexpression andp30
level
Since antigenic specificities associated
to p30 seem to be involved in GCSAa
activity (Ledbetter & Nowinski, 1977;
Snyder et al., 1977, Tung et al., 1977), the
amountofintracellularp30wasdetermined
in a radioimmunoassay and compared to
i s- -I -l --I -4 1' I N- IN 11
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ng p30/mg protein (log)
2 3
FIG. 5. Relationslip between amount of GCSAa and p30 level: (X) G-related MuLV-infected cell
line and regression line (y=l-1055x -8-157; r=+0-88; 0-01<2on<0-05). (D) FMR-
MuLV-infected cell line and - - - regression line (y= 0 0706x 5*6673; r= +0*10; 2f>0 10).
(x) Xenotropic-virus-infected cell line and - -- - regression line (y= 0 2624 x 5 - 7714;
r=+O*48; 2os>0l10).
the level of GCSAa expressed by the same
cells. Statistical analysis of the results is
summarized in Fig. 5 ,where NA50 (i.e. the
level of GCSAa determinants on the cell
surface) was plotted on a log/log scale as a
function of p30 level in ng/mg of protein.
A significant relationship was found be-
tween the level of GCSAa and the level of
intracellular p30 when there was infection
with virus of the G-MuLV group (r =
+ 0588, 0-01 < 2o < 0.05). A lower and
non-significant relationship was found
when cells were infected with mouse
xenotropic viruses (r= +0-48; 2oY>0.10)
and no relationship when cells harbouring
viruses of the FMR-MuLV group were
tested (r= +0410; 2a>0O10).
DISCUSSION
Despite the presence ofseveral antibody
specificities, the anti-(C58NT)D W/Fu
rat serum, when appropriately diluted
and assayed on mouse ESG2 target cells,
recognized mainly if not exclusively
GCSAa, very few Gross-virus-induced
lymphoma cells being needed to absorb
out the cytotoxic activity, whereas RBL5
cells and 129 thymocytes, which defined
the other G-related antigens GCSAb and
GIx, could not absorb out this cytotoxic
activity (Herberman, 1972). Absorption
of anti-GCSAa antibodies has however
been observed with high numbers of
leukaemic cells induced by other agents;
this could be due to a nonspecific phenom-
enon, or to a slight expression of cross-
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reactive moieties on these cells (Herber-
man, 1972).
When in vitro cell lines infected with
ecotropic MuLV were assayed for GCSAa
expression, it appeared that this antigen
can be induced not only by G-type MuLV',
but also after infection with FMR-type
MuLV or xenotropic viruses, these findings
being in agreement with the results
reported by O'Donnel & Stockert (1976).
Since it has been suggested that at least
two subspecificities of the GCSA may
exist, one specific for G-MuLV, the other
common (O'Donnel & Stockert, 1976), it
was then important to determine the fine
specificity of the assay used here. Since in
contrast with O'Donnel and Stockert's
findings (I1976) we never observed a
partial absorption of our anti-(C58NT)D
serum activity by FMR-MuLV or xeno-
tropic-virus-infected cells, it can be as-
sumed that only one GCSAa specificity is
being detected in our assay. Moreover,
when the percentage of absorption was
plotted in log/log scale as a function of
the number of absorbing cells (Fig. 1),
the straight lines obtained with FMR-
MuLV or xenotropic-virus-infected cells
showed the same slope than those obtained
with G-MuLV-infected cells (Table IV).
As hypothesized by Dexter (1976), this
was in favour of a homogeneous antigen-
antibody system involving the same
affinity interactions. Anti-GCSAa anti-
bodies being constant in our system,
GCSAa determinant must be homogen-
eous on the various infected cultured cells.
Furthermore, it is not unlikely that the
GCSAa specificity we observed with the
rat anti-(C58NT)D serum could represent
the GCSA subspecificity common to G,
FMR and xenotropic MuLV recognized by
the C57BL/6 anti-AKR K36 lymphoma,
mouse antiserum used in the above-
mentioned studies (O'Donnel & Stockert,
1976). Thus, although the anti-GCSAa
activity of the rat anti-(C58NT)D serum
has been described as a G-MuLV typing
serum when tested on lymphoma cells, it
must be considered only as a MuLV-
group-specific antiserum when tested on
infected cultured fibroblasts. In addition,
the quantitative study of (CSAa ex-
pression has clearly shown that a differ-
ence in the amount of antigen cannot be
used to distinguish in vitro infection of
cells by a G type or FMR type or a
xenotropic virus; a high or intermediate
level of (GCSAa expression could be
induced by G-related MuLV but also by
a FMR type or xenotropic MuLV. Fur-
thermore, within these 3 groups ofviruses,
the level of GCSAa expression varied
when a given cell line was infected with
different virus isolates or when cell lines
were infected by the same virus.
It can then be questioned what mole-
cular species bears the GCSAa activity,
and two molecules have been described as
precipitated by an anti-(C58NT)D serum
from the surface of Gross-virus-induced
lymphoma cells: the envelop protein gp70
amd 2 glycosylated precursors of the
nucleocapsid (gag) proteins (p30, p15,
p12 and plO) with mol. 95,000 and 85,000
(gp85gag and gp95gag) (Tung et al., 1977).
Although we had no direct evidence, it is
not unlikely that, in this experiment, the
GCSAa specificity detected by the anti-
(C58NT)D serum, though MuLV-group
specific, was borne by the gp95gag and
gp85gag molecules, since the gp7O is also
well expressed on the FMR-MuLV lym-
phomas cells (Bauer, 1974). Moreover, the
GCSA as defined by the mouse antiserum
has been described to be borne also by
gp85gag and gp95gag (Ledbetter & Now-
inski 1977, Snyder et al., 1977, Ledbetter
et al., 1978). The discrepancy in specificity
of the expression of GCSAa, which
appears Gross-virus-specific on MuLV-
induced leukaemias but nonspecific Gross
virus on MuLV-infected fibroblasts, could
be related to a weak or null expression of
gp95gag or gp85gag on FMR-MuLV-in-
duced lymphoma cells (Ledbetter et al.,
1977), while FMR-virus-infected fibro-
blasts could express them (Evans et al.,
1977; Edwards & Fan 1979; Schultz et al.,
1979; Buetti & Diggelman 1980). In
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accordance with this hypothesis, FMR-
MuLV-induced lymphoma cells have been
shown not to express p30 antigenic
specificities at their surface (Humphrey
et al., 1979; Nowinski et al., 1978;
Schneider & Hunsmann, 1978).
Antigenic sites associated with p30
molecules being at least partially involved
in the GCSAa specificity (Ledbetter &
Nowinski, 1977; Snyder et al., 1977), it
could be questioned whether the GCSAa
expression is related to the level of
intracellular nucleocapsid proteins, a re-
flection of the virus-cell metabolic inter-
action. A good relationship was found
between the GCSAa level and the amount
of intracellular p30 when the cells are
infected with the G-type viruses, suggest-
ing a homogeneous event. On the contrary
no relationship was found during a
FMR-MuLV or xenotropic virus infection.
The absence of striking evidence for a
relationship or independence, when cells
were infected by xenotropic virus, would
probably be due to the heterogeneity of
xenotropic viruses (O'Donnel & Stockert
1976). It is not unlikely that the absence
of relationship between the amount of
GCSAa and the p30 level in the case of
FMR-MuLV infection was due to the
MuLV group-specific determination of
GCSAa and p30. This overall relationship
could be very different from a relationship
studied in MuLV-type specific conditions,
if, for example, one of these products is
the result of two different proviral ex-
pressions (one FMR and one endogeneous)
as shown recently (Tung & Fleissner
1980). However, this result can be com-
pared with the recent findings that during
FMR-MuLV infection the gag products
expressed on the cell surface and the
intracellular nucleocapsid proteins could
result from two different metabolic path-
ways (Edwards & Fan, 1979; Ledbetter
et al., 1978; Schultz et al., 1979) and,
obviously, studies with MuLV-type-speci-
fic antisera and molecular determination
of the antigen are needed.
These in vitro findings could explain
the different antigenic specificity found
between Gross and FMR virus-induced
lymphomas, the gag precursor associated
GCSA antigens persisting at the cell
surface in the first case but not in FMR
virus-induced tumours.
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providing 129 mice, Dr R. Ravicovich and E.
Leftheriotis for providing in vitro cell lines, and to
F. Pozo and J. P. Portail for their skilful technical
assistance. We also thank Dr J. P. Levy for helpful
advice and discussions.
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